Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-11
1994-05-10
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483137, C07D40312, A61K 31415
Patent
active
053107489
ABSTRACT:
Disclosed are imidazoles as inhibitors of acylCoA:cholesterol acyltransferase (ACAT), processes for their preparation, pharmaceutical compositions, and their use as antihypercholesterolemics and/or antiatherosclerotics.
REFERENCES:
patent: 4228291 (1980-10-01), Durant et al.
patent: 4413130 (1983-10-01), White
patent: 4460598 (1984-07-01), Lautenschlager et al.
patent: 4623662 (1986-11-01), DeVries
patent: 4654358 (1976-03-01), Lautenschlager et al.
patent: 4722927 (1988-02-01), Holmes
patent: 4824843 (1989-04-01), Hoefle et al.
patent: 4868210 (1989-09-01), Trivedi
patent: 4882357 (1989-11-01), Creger et al.
patent: 4900744 (1990-02-01), Billheimer et al.
Billheimer Jeffrey T.
Higley C. Anne
Wexler Ruth R.
Wilde Richard G.
Ferguson Blair Q.
Springer David B.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Imidazoles for the treatment of atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoles for the treatment of atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoles for the treatment of atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2412454